This bill requires medical cannabis dispensaries and caregivers to test all cannabis products before selling them to patients, ensuring they meet safety standards for contaminants like pesticides, microbes, and THC potency (max 10mg per serving, with a 10% variance allowance). It mandates testing for harmful substances including pesticides, molds, and PFAS, and requires detailed record-keeping of test results. The bill also directs a portion of adult-use cannabis tax revenue to fund medical cannabis programs and creates a study group to review the program’s effectiveness. These changes directly affect medical cannabis patients, dispensaries, and caregivers in Maine by aligning safety protocols with adult-use standards.
LD 182 requires Maine's Department of Health and Human Services to set MaineCare reimbursement rates for Maine Veterans' Homes on a per-resident daily basis. This directly affects veterans' facilities (including nursing homes and residential care facilities operated by Maine Veterans' Homes) and ensures MaineCare covers the portion of their operating costs tied to residents receiving MaineCare benefits. The bill mandates annual inflation adjustments to these rates and allows the department to use data from other states or hire third parties to establish them. It does not change eligibility but standardizes how costs for covered residents are calculated and reimbursed.
This bill amends Maine's optometry practice laws to clarify the scope of services optometrists can provide. It explicitly permits optometrists to prescribe hydrocodone combination products and other controlled substances (such as schedule III-V drugs) for eye conditions, while listing specific procedures excluded from optometry practice (e.g., corneal transplants, retinal surgery, and surgeries requiring general anesthesia). The bill also requires optometrists to meet board-established credentialing standards before performing any ophthalmic surgery or laser procedures. These changes directly affect Maine optometrists by defining their prescribing authority and procedural boundaries.
LD 93 expands Maine's Universal Childhood Immunization Program to cover all adults residing in the state, not just children under 19. The bill amends existing law to define "individual" as any Maine resident and modifies program administration to include adults in the vaccine coverage. It maintains the same funding mechanism through the Childhood Immunization Fund, requiring assessed entities (like insurance providers) to pay quarterly assessments based on the number of covered residents. This change aims to reduce costs and increase access to recommended vaccines for all age groups by extending the existing childhood program framework.
LD 532 expands Maine's assault law to specifically protect all health care workers in hospital emergency rooms. The bill defines assault on these workers as a Class C crime, covering anyone employed or contracted by a state-licensed health care entity (including hospitals and clinics) while performing their job in the emergency room. This change directly affects health care workers in Maine's emergency departments by strengthening legal consequences for assaults against them. The key provision amends existing statute §752-F to broaden the definition beyond previous limitations, ensuring all licensed health care workers in emergency settings receive the same legal protection.
LD 886 regulates medication abortions in Maine by requiring in-person consultations and prescriptions from licensed health care professionals. It prohibits purchasing or obtaining medication abortion drugs online and mandates that providers explain the process, expected experiences, physical/emotional/spiritual risks, and potential reversal options to patients. The bill directly affects individuals seeking medication abortions and the health care professionals who provide them. These provisions aim to standardize access and information for medication abortions under Maine law.
LD 887 requires health care providers to be physically present during chemical abortions, including examining the patient, scheduling a follow-up within 7 days, and providing a labeled catch kit and medical waste bag for proper disposal. It makes manufacturers of abortion drugs liable for the proper disposal of the drugs and cleanup if endocrine disruptors (chemicals interfering with hormones) are found in wastewater, imposing $20,000 civil penalties for violations. The bill directly affects providers prescribing abortion drugs, manufacturers of these drugs, and patients receiving chemical abortions. Exceptions apply only for life-threatening medical emergencies. This bill does not change the legal status of abortion but adds specific procedural and disposal requirements.
LD 253 repeals Maine Revised Statutes, Title 22, section 3196, which previously required the MaineCare program (Maine's Medicaid program) to cover abortion services for enrollees. This bill removes the mandate that the Department of Health and Human Services fund abortion services, including state funding when federal Medicaid does not cover them. As a result, MaineCare would no longer be required to cover abortion services for its members. The bill directly affects MaineCare enrollees who previously had access to this coverage under the repealed law.
LD 682 requires healthcare providers to report abortion procedures to Maine's Department of Health and Human Services, including patient demographics like race, marital status, and education level, as specified by national public health standards. It changes the standard for abortions after fetal viability to allow them only when medically necessary to preserve the mother's life or health, or when a fetus has a "lethal fetal anomaly" (a condition likely to cause the baby's death within three months after birth). The bill reinstates criminal penalties for unlicensed individuals performing abortions or assisting unlicensed providers, and clarifies that only licensed physicians, physician assistants, or advanced practice nurses may perform abortions. These changes directly affect abortion providers, patients receiving care, and state health data collection.
LD 1712 amends Maine's Paid Family and Medical Leave program to adjust requirements for employees and employers. It requires employees to give reasonable notice before taking leave and allows employers to deny leave based on specific, defined hardships (such as having fewer than 15 employees, a summer labor shortage, or more than 25% of staff already on leave), without review of such decisions. The bill also revises benefit calculations to replace 65% of average weekly wage (with 90% replacement for wages up to 50% of the state average and 66% for higher wages), shortens application deadlines for benefits (with waivers for good cause), and modifies premium payments so employers deduct 50% of the cost from employee wages while covering the remaining 50%.
